Xavier Study Links Respiratory Illness to Vaccine Choices

By Delatria Palacios

The COVID-19 pandemic has highlighted the importance of early symptom management, adherence to public health guidelines and staying up to date on COVID-19 vaccinations to reduce the risk of severe illness and death. Yet, vaccine hesitancy continues to pose significant challenges, particularly among certain populations.

Respiratory Diseases including asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), emphysema, influenza, and respiratory syncytial virus (RSV) remain major health concerns globally. These challenges have been compounded by the onset of COVID-19, emphasizing the need to examine decisions toward vaccination and understanding of respiratory illness. This article explores how experiences with respiratory diseases influence perceptions of COVID-19 vaccines among students and staff at Xavier University of Louisiana.

People living with respiratory conditions face a significantly higher risk of developing severe complications from COVID-19. These may include prolonged recovery times, frequent hospitalizations, intensified respiratory symptoms, and increased mortality. Given this elevated risk, it is crucial to understand how experiences shape decisions of getting vaccinated.

Research suggests that personal experiences with illness play a pivotal role in shaping decisions toward vaccination. Those who have experienced severe respiratory disease symptoms or have witnessed the effects of COVID-19 on loved ones, friends, or colleagues may be more likely to prioritize getting vaccinated. In contrast, those with milder symptoms or limited exposure to COVID-19 may approach vaccination with greater hesitation.

A recent follow-up survey conducted across 10 healthcare facilities in Southeastern Louisiana offers valuable insight into these dynamics. Among 299 participants, nearly half (47%) reported a history of respiratory illness. Those with a prior respiratory diagnosis were significantly more likely to accept the latest COVID-19 vaccine (62%) compared to those without (41%) (RR: 1.79, 95% CI: 1.26–2.56). Moreover, individuals who previously accepted the influenza vaccine were more likely to receive the updated COVID-19 vaccine (RR: 1.87, 95% CI: 1.06–3.28).

Complimenting these findings, Xavier University of Louisiana conducted its own study that offers valuable insights into the complex factors influencing COVID-19 vaccine decisions among individuals with respiratory conditions. Through surveys of staff and students living with these health challenges, the research delved into their personal experiences, concerns, and motivations surrounding COVID-19 vaccination.

The study revealed several key findings:

Heightened vulnerability: Participants living with respiratory diseases voiced concerns about experiencing intense symptoms and a greater likelihood of hospitalization.
Personal experience and vaccine decision-making: Many participants shared that their experiences with respiratory illness strongly influenced their choice to get vaccinated, whether to protect themselves or to safeguard loved ones such as spouses, children, or parents.
Trusting the science and healthcare providers: Confidence in scientific evidence and the guidance of healthcare professionals played a role in shaping participants’ vaccine decisions.
Concerns about vaccine safety and efficacy: Despite recognizing their vulnerabilities, some participants expressed hesitation due to concerns about vaccine safety, effectiveness, and its relatively recent development, highlighting the continued need for clear, empathetic education and community-based support.

Together, these studies provide critical insight into how respiratory illness and past vaccination experiences shape decisions toward COVID-19 vaccines. They carry important implications for public health initiatives aimed at increasing vaccine confidence among vulnerable populations. By acknowledging personal experiences and fostering trust in science and healthcare providers, health leaders can build more effective, community-centered strategies.